| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 862,500 | 53,691,000 | 29.65% | Put | |
| 2 | ISHARES TR | 20,000 | 6,067,000 | 3.35% | ||
| 3 | CLOVIS ONCOLOGY INC | 58,567 | 5,386,000 | 2.97% | ||
| 4 | INCYTE | 47,400 | 5,230,000 | 2.89% | ||
| 5 | ALEXION PHARMACEUTIC | 33,021 | 5,164,000 | 2.85% | ||
| 6 | CELGENE CORP | 47,137 | 5,099,000 | 2.82% | ||
| 7 | BIOGEN INC | 17,467 | 5,097,000 | 2.81% | ||
| 8 | ALKERMES PLC SHS | 86,864 | 5,096,000 | 2.81% | ||
| 9 | MEDIVATION INC | 118,372 | 5,031,000 | 2.78% | ||
| 10 | ILLUMINA INC | 28,334 | 4,982,000 | 2.75% | ||
| 11 | REGENERON PHARMACEUTICALS | 10,627 | 4,943,000 | 2.73% | ||
| 12 | NEKTAR THERAPEUTICS COM | 444,258 | 4,869,000 | 2.69% | ||
| 13 | SEATTLE GENETICS INC | 124,558 | 4,803,000 | 2.65% | ||
| 14 | BIOMARIN | 42,012 | 4,425,000 | 2.44% | ||
| 15 | BIO TECHNE CORP | 47,000 | 4,346,000 | 2.40% | ||
| 16 | ASTRAZENECA PLC | 136,000 | 4,328,000 | 2.39% | ||
| 17 | METTLER-TOLEDO | 15,200 | 4,328,000 | 2.39% | ||
| 18 | VERTEX PHARMACEUT | 40,876 | 4,257,000 | 2.35% | ||
| 19 | QIAGEN NV | 160,000 | 4,128,000 | 2.28% | ||
| 20 | IONIS PHARMACEUTICAL | 101,401 | 4,099,000 | 2.26% | ||
| 21 | CEPHEID | 90,000 | 4,068,000 | 2.25% | ||
| 22 | ALNYLAM PHARMACEUTICALS INC | 48,448 | 3,893,000 | 2.15% | ||
| 23 | AGIOS PHARMACEUTICALS INC | 46,000 | 3,247,000 | 1.79% | ||
| 24 | BRISTOL MYERS SQUIBB CO | 36,000 | 2,131,000 | 1.18% | ||
| 25 | MERCK & CO INC | 41,000 | 2,025,000 | 1.12% | ||
| 26 | PROSHARES TR | 32,717 | 1,906,000 | 1.05% | ||
| 27 | HOLOGIC INC | 48,000 | 1,878,000 | 1.04% | ||
| 28 | NANOSTRING TECHNOLOGIES INC | 102,200 | 1,635,000 | 0.90% | ||
| 29 | ARRAY BIOPHARMA INC COM | 250,000 | 1,140,000 | 0.63% | ||
| 30 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 56,788 | 926,000 | 0.51% | ||
| 31 | VERICEL CORP | 332,157 | 900,000 | 0.50% | ||
| 32 | ZOGENIX INC | 65,700 | 887,000 | 0.49% | ||
| 33 | PACIRA BIOSCIENCES INC | 21,000 | 863,000 | 0.48% | ||
| 34 | AMGEN INC | 5,626 | 778,000 | 0.43% | ||
| 35 | Curis, Inc | 374,500 | 756,000 | 0.42% | ||
| 36 | ACHILLION PHARMACEUTICALS INC COM | 106,104 | 733,000 | 0.40% | ||
| 37 | UNITED THERAPEUTICS | 5,571 | 731,000 | 0.40% | ||
| 38 | NOVAVAX INC COM | 100,000 | 707,000 | 0.39% | Put | |
| 39 | NOVAVAX INC COM | 100,000 | 707,000 | 0.39% | Call | |
| 40 | STEMLINE THERAPEUTICS INC | 75,000 | 662,000 | 0.37% | ||
| 41 | EPIZYME INC COM | 46,079 | 593,000 | 0.33% | ||
| 42 | CHIMERIX INC | 14,152 | 541,000 | 0.30% | ||
| 43 | SANOFI SPOND FUNSPONSORED ADR | 62,009 | 528,000 | 0.29% | ||
| 44 | REPROS THERAPEUTICS INC | 98,000 | 494,000 | 0.27% | Call | |
| 45 | GILEAD SCIENCES INC | 4,323 | 424,000 | 0.23% | ||
| 46 | AXOVANT SCIENCES LTD | 30,722 | 397,000 | 0.22% | ||
| 47 | INFINITY PHARMACEUTICALS INC COM | 45,300 | 383,000 | 0.21% | ||
| 48 | Arrowhead Pharma Inc | 51,133 | 295,000 | 0.16% | ||
| 49 | OPHTHOTECH CORP COM | 7,150 | 290,000 | 0.16% | ||
| 50 | NATIONAL HOLDINGS CORP COM NEW | 89,530 | 246,000 | 0.14% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-003444, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
